In this issue of Cancers, Kelp et al. used a conditional Pten loss-of-function mouse model of endometrial cancer to demonstrate that Pgrmc2 deficiency attenuated the development of endometrial hyperplasia and cancer and prolonged survival. This evidence concerns the gene PTEN and endometrial cancer.